ow FODMAPs diet in patients with IBS-D
- Conditions
- Irritable bowel syndrome.Irritable bowel syndrome with diarrhoea
- Registration Number
- IRCT2017093033308N1
- Lead Sponsor
- Vice Chancellor for research; Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 110
. Inclusion criteria for participants' enrollment were IBS with diarrhea subtype (Bristol Stool Form Scale = 5) and age 20-60 years old. Exclusion criteria were having a confounder medical condition such as celiac disease, inflammatory bowel disease (IBD) or presence of cardiovascular, liver, kidney, neurologic diseases, diabetes and thyroid disorders, consumption of ?-3 FAs and other nutritional supplements in the last 3 months, pregnancy in during the study. The use of effective drugs against IBS such as drugs affecting GI motility was not allowed, but antidepressants drugs were allowed on a stable dose for the last 3 months before inclusion.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gastrointestinal symptoms. Timepoint: 3 weeks. Method of measurement: questionnaire.;Bowel habit status. Timepoint: 6 weeks. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method Quality of life. Timepoint: 6 weeks. Method of measurement: questionnaire.